301211 亨迪药业
2026/03 - 三个月2025/122024/122023/122022/12

盈利能力分析
净资产收益率 ROE (%)0.4051.5243.9247.6025.592
总资产报酬率 ROA (%)0.3841.4283.6366.9815.210
投入资产回报率 ROIC (%)0.4001.5073.8717.4095.477

边际利润分析
销售毛利率 (%)20.92722.10528.84140.17228.878
营业利润率 (%)8.5309.23322.62630.96928.884
息税前利润/营业总收入 (%)8.9416.92211.37822.95515.967
净利润/营业总收入 (%)7.6717.70120.53326.56224.430

收益指标分析
经营活动净收益/利润总额(%)10.25732.56878.54096.29694.033
价值变动净收益/利润总额(%)72.24470.61318.9501.9820.000
营业外收支净额/利润总额(%)-0.004-1.441-0.461-1.242-0.871

偿债能力分析
流动比率 (X)17.17915.64011.40411.98410.660
速动比率 (X)15.97314.56910.56510.99210.111
资产负债率 (%)4.9015.3567.1917.4578.895
带息债务/全部投入资本 (%)0.7380.4470.4890.9322.985
股东权益/带息债务 (%)13,363.07722,120.75420,215.89110,560.3443,230.841
股东权益/负债合计 (%)1,940.3911,766.9981,290.5661,241.1041,024.271
利息保障倍数 (X)21.768-3.175-1.021-3.007-1.260

营运能力分析
应收账款周转天数 (天)50.76244.51340.80433.69670.748
存货周转天数 (天)117.695132.808176.813130.916100.365